Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1654 1658 1676 1691
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18035267 | PEPTIDES FROM HUMAN B-CASEIN THAT HAVE ANTI-BACTERIAL ACTIVITY | Final Rejection | The Regents of the University of California |
| 18004104 | HUMAN RECOMBINANT ACE2-FC MUTANTS THAT DECOUPLE ANTI-SARS-COV-2 ACTIVITY FROM CARDIOVASCULAR EFFECTS | Final Rejection | Northwestern University |
| 17323683 | CBX8 CHROMDOMAIN INHIBITORS AND THE USES THEREOF | Non-Final OA | Purdue Research Foundation |
| 18352345 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | Non-Final OA | NOVARTIS AG |
| 18246063 | POLYMERS AND NANOPARTICLE FORMULATIONS FOR SYSTEMIC NUCLEIC ACID DELIVERY | Non-Final OA | The Johns Hopkins University |
| 17628142 | SEPARATED PEPTIDE | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
| 18250406 | PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME | Non-Final OA | IDEMITSU KOSAN CO.,LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy